ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION

Lobbying client · District of Columbia · filed 2025 to 2026

trade association representing the advanced medical technology industry

$120,000 Reported spend

7 Filings counted

1 Outside firm hired

3 Bills named

Spend is reported income plus in-house expenses across 7 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. Everything on this page comes from one LDA client record (212417), filed by the registrant listed below.

Who filed for this client 1

EMERGENT STRATEGIES $120,000 Outside firm · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 3

S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025

6 filings
H.R. 1691
Ensuring Patient Access to Critical Breakthrough Products Act of 2024

1 filing
S. 5349
Ensuring Patient Access to Critical Breakthrough Products Act of 2024

1 filing

Reported by year 2 years

2026 $45,000 3 filings
2025 $75,000 4 filings

Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 7
SENATE 7

Recent filings 8 total

Q3 report

EMERGENT STRATEGIES

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $15,000 income · posted Oct 20, 2026

View → Q2 report

EMERGENT STRATEGIES

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $15,000 income · posted Jul 17, 2026

View → Q1 report

EMERGENT STRATEGIES

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $15,000 income · posted Apr 20, 2026

View → Q4 report

EMERGENT STRATEGIES

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $15,000 income · posted Jan 20, 2026

View → Q3 report

EMERGENT STRATEGIES

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $15,000 income · posted Oct 20, 2025

View → Q2 report

EMERGENT STRATEGIES

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $15,000 income · posted Jul 21, 2025

View → Q1 amendment

EMERGENT STRATEGIES

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $30,000 income · posted Apr 21, 2025

View → Q1 report

EMERGENT STRATEGIES Amended

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $45,000 income · posted Apr 21, 2025

View →

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.